Fine-tuning the cytotoxicity of ruthenium(<scp>ii</scp>) arene compounds to enhance selectivity against breast cancers-Reference-Cited by-同舟云学术

Fine-tuning the cytotoxicity of ruthenium(ii) arene compounds to enhance selectivity against breast cancers

Published:2023 Issue:33 Volume:52 Page:11679-11690
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Pereira Sarah A. P.¹²,Romano-deGea Jan²^ORCID,Barbosa Ana Isabel¹^ORCID,Costa Lima Sofia A.¹,Dyson Paul J.²^ORCID,Saraiva M. Lúcia M. F. S.¹^ORCID

Affiliation:

1. LAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, no 228, 4050-313 Porto, Portugal

2. Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland

Abstract

A ruthenium(ii) arene compound was identified as the most promising candidate for breast cancer treatment amongst a library of rationally designed and fully synthesized compounds where the impact of different counterions’ cytotoxicity was evaluated.

Funder

Fundação para a Ciência e a Tecnologia

Ministério da Ciência, Tecnologia e Ensino Superior

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/DT/D3DT02037A

Reference96 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cisplatin in cancer therapy: Molecular mechanisms of action

3. Cisplatin–gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients

4. Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruthenium compounds: Are they the next‐era anticancer agents?;Applied Organometallic Chemistry;2024-01-29

2. Recent trends in the design and delivery strategies of ruthenium complexes for breast cancer therapy;Dalton Transactions;2024